Reach Us +1-947-333-4405


B Lymphocytes Regulate A Pro-inflammatory T Cell Balance In Human Type 2 Diabetes | 9234
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

World Congress on Pathology and Microbiology

Manila, Philippines
Google scholar citation report
Citations : 1147

Journal of Clinical & Experimental Pathology received 1147 citations as per google scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

B lymphocytes regulate a pro-inflammatory T cell balance in human type 2 diabetes

2nd International Conference and Exhibition on Pathology

Jason DeFuria, Madhu Jagannathan-Bogdan, Ramya Kuchibhatla, Marie McDonnell, Caroline Apovian, Barbara Nikolajczyk and Gerald Denis

Accepted Abstracts: J Clin Exp Pathol

DOI: 10.4172/2161-0681.S1.010

Lymphocytes play key roles in the chronic inflammation critical for T2D pathogenesis. We have shown T2D patients have an elevated ratio of pro- to anti-inflammatory T cells, and B cells that produce a pro-inflammatory cytokine profile. Thus lymphocytes promote T2D-associated inflammation. Although the pro-inflammatory CD4 + T cell balance has been specifically implicated in T2D pathogenesis by numerous studies, mechanisms that underlie elevated CD4+ T cell inflammation are poorly understood. B cells have recently become appreciated as regulators of CD4+ T cell subset differentiation and function, but the possibility that the T2D-associated changes we identified in B cell function regulate T cell inflammation in T2D is untested. Our new data demonstrate that B cells control the T2D-associated increase in CD4+ Th17-mediated inflammation in both T2D patients and in obese/insulin resistant mice. Surprisingly, the disease-associated ability of B cells to regulate T cell function was contact-dependent, despite the demonstration that multiple cytokines hyper-secreted by B cells from T2D patients activate T cells. In contrast, elevated activation of CD4+ Th1 axis cytokines was B cell-independent. We conclude that both T cell-intrinsic and T cell-extrinsic changes regulate T cell-mediated inflammation in T2D. These data indicate that B cell depletion may partially curb T2D-associated T cell inflammation thus disease pathogenesis, but that combinatorial treatments may be required for favorable clinical outcomes. Thus our work suggests that the currently modest efficacy of anti-inflammatory drugs in T2D may be predictable, and that drug combinations will be required to leverage our understanding of T2D as an inflammatory disease into new treatments. Ja